Smiths Detection

Roche Molecular Systems has been awarded US Patent No. 8,329,884, "Reagents and methods for detecting Neisseria gonorrhoeae."
Diane Kawa, Shi-Da Lu, and Peter Dailey are named as inventors.

Scientists from Stellenbosch University in South Africa have been awarded $131,000 from the National Institutes of Health for the first year of a planned four-year project aimed at developing and evaluating a molecular assay for multi- and extreme-drug-resistant tuberculosis usin

This story has been updated to include an additional patent.
Smiths Detection has been awarded US Patent No. 8,138,909, "Portable detection system and method."

Geneohm Sciences Canada (Becton Dickinson) has been awarded US Patent No.

Smiths Detection Diagnostics and Novartis Diagnostics plan to develop and market highly multiplexed assays for a variety of infectious diseases, beginning with a focus on healthcare-associated infections.

Novartis Diagnostics will take the Bio-Seeq molecular diagnostic tests for infectious disease through clinical trials and on to commercialization.

Patents awarded to Gen-Probe, Fujifilm, and Smiths Detection

The company will collaborate with UC Davis to develop a test for eight microbes that cause sepsis in burn and wound patients.

The company will use $2.2 million to develop a PCR-based multiple flu test.

The UK-based company will offer the toolkit through a single license that combines IP it licensed from Brandeis University and PHRI Properties, the tech-transfer arm of the University of Medicine and Dentistry of New Jersey.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.